Impact of The Teal Run: Dr. Daniel Heller's Work on AI early detection

Your support funds real breakthroughs.

The Teal Foundation helped support innovative research led by Dr. Daniel Heller at Memorial Sloan Kettering Cancer Center through OCRA's Collaborative Research Development Grant. Thank you for being part of the progress toward earlier detection and better outcomes for women everywhere.

Here is what that support is helping to advance:

The Problem: Ovarian cancer is often detected too late. Nearly 70% of cases are diagnosed at advanced stages, when outcomes are far more serious.

What They Built: Researchers created over 150 different nanosensors that react to molecules in the blood.

These sensors can:

• Detect differences between cancer and non-cancer samples

• Identify patterns linked to ovarian cancer

The system has already shown strong performance in earlier work:

• 87% sensitivity and 98% specificity for late-stage cancer detection

The Key Idea: Instead of looking for one marker (like CA125), this approach:

• Looks at many molecular interactions at once

• Uses AI to recognize patterns

This creates a more accurate “signature” of disease.

What They Achieved:

• Built and optimized this new sensor technology

• Tested it on 600+ patient samples

• Identified sensors that can distinguish between:   

– Ovarian cancer    – Other cancers    – Benign conditions

They also discovered that these sensors can capture important cancer-related proteins - which may become new biomarkers for earlier detection.

The Challenge: Very few early-stage samples exist - because ovarian cancer is rarely caught early today.

Why This Matters:

This research is laying the groundwork for detecting ovarian cancer earlier, improving outcomes, and ultimately saving lives.

This is what your support makes possible.